Article
Low level of antifungal resistance of Candida glabrata blood isolates in Turkey: Fluconazole minimum inhibitory concentration and FKS mutations can predict therapeutic failure.
Mycoses - 1 Sept 2020
Arastehfar Amir, Daneshnia Farnaz, Salehi Mohammadreza, Yaşar Melike, Hoşbul Tuğrul, Ilkit Macit, Pan Weihua, Hagen Ferry, Arslan Nazlı, Türk-Dağı Hatice, Hilmioğlu-Polat Süleyha, Perlin David S, Lass-Flörl Cornelia
Abstract excerpt
BACKGROUND: Candida glabrata is the third leading cause of candidaemia in Turkey; however, the data regarding antifungal resistance mechanisms and genotypic diversity in association with their clinical implication are limited. OBJECTIVES: To assess genotypic diversity, antifungal susceptibility and mechanisms of drug resistance of C glabrata blood isolates and their association with patients' outcome in a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.